3,6-Dichloropyrazinum-2-Carbonitrile CAS 356783-16-9 Puritas ≥99.0% (HPLC) Favipiravir Intermedia COVID-19 Featured Image

3,6-Dichloropyrazinum-2-Carbonitrile CAS 356783-16-9 Puritas ≥99.0% (HPLC) Favipiravir COVID-19

Description:

Nomen chemica: 3,6-Dichloropyrazinum-2-Carbonitrile

CAS: 356783-16-9

Aspectus: Pallida Yellow ad Off-Pulvis alba

Puritas: ≥99.0% (HPLC)

Medium Favipiravir (CAS: 259793-96-9) in curatione aegrorum COVID-19 commendatarum a WHO

High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio:

Commercial Supple Favipiravir et intermedia:
Favipiravir CAS 259793-96-9
2-Aminopropanediamide CAS 62009-47-6
Diethyl Aminomalonatum Hydrochloridum CAS 13433-00-6
3,6-Dichloropyrazinum-2-Carbonitrile CAS 356783-16-9
3,6-Difluoropyrazine-2-Carbonitrile CAS 356783-28-3
6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile CAS 356783-31-8
6-Bromo-3-Hydroxypyrazine-2-Carboxamide CAS, 259793-88-9
3-Hydroxypyrazine-2-Carboxamide CAS 55321-99-8

Chemical Properties:

Nomen chemicum	3,6-Dichloropyrazinum-2-Carbonitrile
Synonyma	3,6-Dichloro-2-Pyrazinecarbonitrile;Favipiravir immunditia 18
CAS Number	356783-16-9
CATTUS Number	RF-PI226
Stock Status	In Stock, Productio Ascendite ad Tons
Formulae hypotheticae	C5HCl2N3
M. Pondus	173.99
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Aspectus	Pallidus ad Off-White pulveris
Lepidium sativum HPLC	Retentione temporis maioris culminis secundum relationem vexillum
Humor (KF)	≤1.0%
Residere in Ignition	≤0.30%
una immunditia	≤0.5%
Totalis immunditias	≤1.0%
Metalla gravis	≤20ppm
Puritas	≥99.0%
Test Standard	Enterprise Standard
Consuetudinem	Favipiravir (CAS: 259793-96-9)

Sarcina & Repono:

sarcina: Utrem, aluminium foil, pera, cardboard Drum, 25kg/Drum, vel secundum exigentiam emptoris.

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine, humore et pestis infestatione.

commoda:

FAQ:

Applicatio:

Shanghai Ruifu Chemical Co., Ltd. est primarium fabrica et supplementum 3,6-Dichloropyrazini-2-Carbonitrile (CAS: 356783-16-9) cum qualitate alta.Itmedium est typice in synthesi 6-Fluoro-3-Hydroxypyrazine-2-Carboxamide commercium nomine Favipiravir (CAS: 259793-96-9).
Favipiravir (CAS: 259793-96-9) in curatione Influentiae virus infectionum.Favipiravir medicamentum latum-spectrum antivirale est quod medicinae moderatoris Generalis Indiae (DCGI) proxima septimana purgatum est pro usu inter aegros Covid-19 subitis.Glenmark vendet genericam favipiravir notam fub nomine FabiFlu.Favipiravir in recentibus 1990s primum processit a societate quae postea a firma Fujifilm Iaponica acquisita est ut pars eius transitus e negotio phocatico ad curis.Post probatum contra varias virus virus, medicamentum in Iaponia anno 2014 probatum est ad usus necessarios contra morbos epidemicos vel novos modos influentiae tractandas.